# Versiti Indiana, Inc. – FDA Inspection, Aug 4, 2023

Source: https://www.keypedia.com/records/fda_inspections/versiti-indiana-inc/d4eb9770-d445-458a-b273-6bfbeee80699
Source feed: FDA_Inspections

> FDA inspection 1214844 of Versiti Indiana, Inc., August 04, 2023. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1214844
- Company Name: Versiti Indiana, Inc.
- Inspection Date: 2023-08-04
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1264016 - 2025-03-11
- FDA Inspection 1032128 - 2017-11-01
- FDA Inspection 957611 - 2016-02-02
- FDA Inspection 884440 - 2014-06-24
- [FDA Inspection 799301 - 2012-09-18](https://www.keypedia.com/records/fda_inspections/versiti-indiana-inc/149a2d10-a657-47db-a6d8-ebd42bd55a0f)

## Related Officers

- [Investigator](https://www.keypedia.com/people/lesley-mae-p-lutao/bfdcc755-28e5-4caf-91f9-b9579df4731e)

Company: https://www.keypedia.com/companies/versiti-indiana-inc/a2677956-ef4b-4464-8f64-030e8666e19a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d